Phase I Clinical Study of Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke
The study is to determine the safety of human neural stem cell transplantation for the treatment of paralysis and related symptoms due to chronic motor stroke and to determine the maximum tolerated dose.
100 项与 Suzhou Neuralstem Biopharmaceutical Co., Ltd 相关的临床结果
0 项与 Suzhou Neuralstem Biopharmaceutical Co., Ltd 相关的专利（医药）
100 项与 Suzhou Neuralstem Biopharmaceutical Co., Ltd 相关的药物交易
100 项与 Suzhou Neuralstem Biopharmaceutical Co., Ltd 相关的转化医学
